This summer, BMD achieved a significant milestone by completing an installation and training session at Noordwest Ziekenhuisgroep – Alkmaar, one of our key customers in the Netherlands. We are extremely proud to announce that with this installation, the very first Helios device is becoming operational in the Benelux region! This advanced device facilitates fully automated IFA, setting a new benchmark in autoimmunity.

It will support a comprehensive array of assays, such as ANA, ANCA, Endomysium, and many more. We look forward to a productive collaboration and are dedicated to assisting our client in establishing themselves as a leading reference in the diagnostic market across the Benelux.